Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy Ablation to Treat Peripheral Lung Cancer: A Second Phase Pilot Study

NCT06262555 is registered in ClinicalTrials.gov with Taoyuan General Hospital as lead sponsor.

NCT NCT06262555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06262555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy Ablation to Treat Peripheral Lung Cancer: A Second Phase Pilot Study
Lead sponsor
Taoyuan General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2024
Completion date
December 31, 2024
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung cancer metastatic